Steve Lehrer Email & Phone Number

Us

Consulting Firm to Life Science Companies focusing on commercialization of new technology including biosimilars, molecular diagnostics, pharmaceutical products and bioprocessing/clean technology. Advisor to senior level management and Board of Directors of small to medium sized life science firms. In many cases serve as part of the senior management team with day to day operating responsibilities. Primary areas of focus are in biopharmaceuticals, specialty pharmaceutical, molecular diagnostics and synthetic biology. Currently advise three companies (two public companies and one private company) and serve on 2 private company Board of Directors.

Mumbai, Maharashtra, In

Cipla is a leading Indian Pharmaceutical Company with a presence in over 170 countries. Cipla is renowned for making affordable, world-class medicines that meet the needs of patients across therapies. The Biologicals business is focused on making advances in biopharmaceuticals, molecular medicine and other biology based products affordable and accessible worldwide

Formed Cipla BioTec to “reinvent biosimilars” and make products in all world markets for a price to the patient at less than $2000/year (vs. current pricing of up to $50,000/year). Built 200-person team. Cipla BioTec reached its objectives for it first two products CBT124 (bevacizumab) and CBT127 (trastuzumab) along with negotiating a unique agreement with the Republic of South Africa to build two fully integrated biopharmaceutical manufacturing facilities

Bensalem, Pennsylvania, Us

Optimal Strategix Group focuses on developing and implementing growth strategies based on unique insights into customer decision making and a combination of strategic and operational expertise.

Provides platform that uses biotechnology processes to develop and manufacture chemical and biopharmaceutical products.Leverages 25 year history of bioprocess product development to develop “cleaner, greener and more cost effective” manufacturing solutions

Simi Valley, California, Us

Glycominds is a molecular diagnostic company developing new diagnostic and prognostic tests for autoimmune disorders and cancer. We have one product on the market, IBDX for aid in diagnosis and prognosis of Crohn's Disease and are introducing a second series of products, gMS for aiding the diagnosis and prognosis of Multiple Sclerosis

Bioinformatic and molecular diagnostic company

Genetic Diagnositics Company commercializing genotyping tests to individuals and pharmaceuticals companies

St. Louis, Missouri, Us

St. Louis, Missouri, Us

Commericalization in Agricultural BIotechnology, Pharmaceuticals, Biologics, Biosimilars and Health Care Services. Started several new standalone businesses and Joint Ventures for Monsanto in all three areas. Several successes in building new businesses including one that was sold for $125 million after $7 million of investment. Led Finance and Planning efforts for Crop Protection and Crop Biotechnology R&D efforts

Us

Senior Management Consulting Projects. Focused on developing new service business in the aircraft engine business, improving pharmaceutical R&D productivity and setting up a Japanese JV in the air freight industry

Cincinnati, Ohio, Us

International Technical Brand Manager. Part of team that turned around Pampers business in Japan. Started a Paper Products Company/Plant in Mexico. Supported Paper Product Divisions in Europe. Youngest International Manager at P&G up until I left P&G to go back to business school

Mba, Management

Bse, Chemical Engineering

Ba, Economics